| www |
info |
Adimadhyam S., Lewis J., Simon A., Wolfe A., Smith S., Hou L., Moyner E., Reynolds J., Toh D., Dobes A., Parlett L., Haynes K., Burris J., Dorand J., Long M., and Kappelman M., "Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis" in Inflammatory Bowel Diseases, vol. 30(4), pp. 554--562, April 2024. |
| www |
info |
Cocoros N., Gurwitz J., Cziraky M., Granger C., Harkins T., Haynes K., Li X., Parlett L., Seeger J., Singh S., McMahill-Walraven C., and Platt R., "Pragmatic guidance for embedding pragmatic clinical trials in health plans: Large simple trials aren’t so simple" in Clinical Trials, June 2023. |
| www |
info |
Al-Khatib S., Pokorney S., Al-Khalidi H., Haynes K., Garcia C., Martin D., Goldsack J., Harkins T., Cocoros N., Lin N., Lipowicz H., McCall D., Nair V., Parlett L., McMahill-Walraven C., Platt R., and Granger C., "Underuse of oral anticoagulants in privately insured patients with atrial fibrillation" in American Heart Journal, vol. 229, pp. 110--117, November 2020. |
| www |
info |
Horton D., Yang J., Neikirk A., Huang C., Crystal S., Davidow A., Haynes K., Gerhard T., Rose C., Strom B., and Parlett L., "Impact of the COVID-19 Pandemic on the Management of Juvenile Idiopathic Arthritis: An Analysis of National United States Administrative Claims Data" poster at American College of Rheumatology's ACR Convergence 2022, November 2022. |
| www |
info |
Horton D., Neikirk A., Yang J., Huang C., Crystal S., Davidow A., Haynes K., Gerhard T., Rose C., Strom B., and Parlett L., "Incidence of Juvenile Idiopathic Arthritis During the COVID-19 Pandemic: An Analysis of National United States Administrative Claims Data" poster at American College of Rheumatology's ACR Convergence 2022, November 2022. |
| www |
info |
Parlett L., Yang Y., Huang C., Neikirk A., Davidow A., Haynes K., Gerhard T., Rose C., Strom B., and Horton D., "Healthcare Utilization and Treatment Among Newly Diagnosed and Prevalent Children with Juvenile Idiopathic Arthritis During the First Year of COVID-19 Pandemic in the US" poster at International Society for Pharmacoepidemology's ICPE 2022, August 2022. |
| www |
info |
Parlett L., Gordon A., Sylvestrzak M., White J., Power T., and Barron J., "Hospitalization Rates and Costs Among Real World Users of Sacubitril/Valsartan versus Other Heart Failure Medications" podium at American Heart Association's AHA Scientific Sessions 2018, November 2018. |
